CM
RPRX icon

Capula Management’s Royalty Pharma RPRX Stock Holding History

Capula Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-89,350
Closed -$2.78M – 833
2025
Q1 		$2.78M Buy
+89,350
New +$2.83M 0.02% 171
2024
Q3 		– Sell
-15,470
Closed -$408K – 634
2024
Q2 		$408K Buy
+15,470
New +$429K ﹤0.01% 316
2023
Q3 		– Sell
-15,020
Closed -$462K – 657
2023
Q2 		$462K Buy
+15,020
New +$509K 0.06% 335
2023
Q1 		– Sell
-10,410
Closed -$411K – 916
2022
Q4 		$411K Sell
10,410
-13,030
-56% -$544K 0.04% 620
2022
Q3 		$942K Buy
+23,440
New +$1M 0.12% 411

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $3.44B AUM 20.03% 1-Year Est. Return